Literature DB >> 20082946

The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.

Dimitris Rigopoulos1, George Larios, Andreas D Katsambas.   

Abstract

Acne is one of the most prevalent diseases in dermatology: Millions of people worldwide experience this distressing condition. To determine the appropriate therapeutic strategy, there is a strong need for a standardized classification system of acne. The exact molecular mechanism of action of isotretinoin is not completely understood; however, oral isotretinoin targets simultaneously at all major mechanisms of acne pathogenesis. Various mass media reports about the risk of teratogenicity and depression from isotretinoin usage as well as the creation of intense prevention programs have created an obstacle to the use of the most active available drug against acne, presenting isotretinoin as a very dangerous regimen. According to recommendations of several international experts, which we share, oral isotretinoin may be prescribed not only to patients with severe disease but indications should be broadened to also include patients with less severe forms of acne, especially in cases with scarring, significant psychologic stress, or failure to respond to conventional therapy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082946     DOI: 10.1016/j.clindermatol.2009.03.005

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  15 in total

1.  Severe Nodulocystic Acne not Responding to Isotretinoin Therapy Successfully Treated with Oral Dapsone.

Authors:  Lutfi Al-Kathiri; Tasneem Al-Najjar
Journal:  Oman Med J       Date:  2018-09

2.  Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Authors:  Attila Oláh; Balázs I Tóth; István Borbíró; Koji Sugawara; Attila G Szöllõsi; Gabriella Czifra; Balázs Pál; Lídia Ambrus; Jennifer Kloepper; Emanuela Camera; Matteo Ludovici; Mauro Picardo; Thomas Voets; Christos C Zouboulis; Ralf Paus; Tamás Bíró
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

3.  The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions.

Authors:  James J Leyden; James Q Del Rosso; Eric W Baum
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

4.  Efficacy and safety of low-level light therapy by delicate pulsed light combined with low-dose oral isotretinoin for the treatment of acne vulgaris: a randomized split-face study.

Authors:  Weihui Zeng; Zhao Wang; Youbao Li; Jun Xia; Yu Zhu; Shujuan He; Jing Liu
Journal:  Lasers Med Sci       Date:  2022-07-13       Impact factor: 2.555

Review 5.  Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.

Authors:  Cara H Nelson; Brian R Buttrick; Nina Isoherranen
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

6.  Longitudinal, 3D in vivo imaging of sebaceous glands by coherent anti-stokes Raman scattering microscopy: normal function and response to cryotherapy.

Authors:  Yookyung Jung; Joshua Tam; H Ray Jalian; R Rox Anderson; Conor L Evans
Journal:  J Invest Dermatol       Date:  2014-07-15       Impact factor: 8.551

Review 7.  Update on hidradenitis suppurativa: connecting the tracts.

Authors:  Liza Gill; Melissa Williams; Iltefat Hamzavi
Journal:  F1000Prime Rep       Date:  2014-12-01

8.  Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.

Authors:  Sherman Chu; Lauren Michelle; Chloe Ekelem; Calvin T Sung; Nathan Rojek; Natasha A Mesinkovska
Journal:  Arch Dermatol Res       Date:  2020-11-05       Impact factor: 3.017

9.  Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin.

Authors:  Małgorzata L Kmieć; Anna Pajor; Grażyna Broniarczyk-Dyła
Journal:  Postepy Dermatol Alergol       Date:  2013-12-18       Impact factor: 1.837

10.  Effects of isotretinoin on body mass index, serum adiponectin, leptin, and ghrelin levels in acne vulgaris patients.

Authors:  Bengu Cevirgen Cemil; Havva Hilal Ayvaz; Gulfer Ozturk; Can Ergin; Havva Kaya Akıs; Muzeyyen Gonul; Ercan Arzuhal
Journal:  Postepy Dermatol Alergol       Date:  2016-08-16       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.